A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure
Source · ClinicalTrials.gov: elamipretide
TLDR
ClinicalTrials.gov lists a phase 2 study of elamipretide in patients hospitalized with congestion due to heart failure as completed. The randomized, double-blind, placebo-controlled study evaluated cardiac and renal effects of short-term treatment; the excerpt provides no results.
- 01The study is listed as completed.
- 02Researchers evaluated cardiac and renal effects in hospitalized heart failure patients.
- 03The excerpt reports no efficacy or safety findings.
Why it matters Editorial
The listing documents clinical investigation of elamipretide in heart failure but does not establish whether treatment improved outcomes.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide